1. Home
  2. NVCR vs EFSC Comparison

NVCR vs EFSC Comparison

Compare NVCR & EFSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • EFSC
  • Stock Information
  • Founded
  • NVCR 2000
  • EFSC 1988
  • Country
  • NVCR Jersey
  • EFSC United States
  • Employees
  • NVCR N/A
  • EFSC N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • EFSC Major Banks
  • Sector
  • NVCR Health Care
  • EFSC Finance
  • Exchange
  • NVCR Nasdaq
  • EFSC Nasdaq
  • Market Cap
  • NVCR 1.8B
  • EFSC 2.0B
  • IPO Year
  • NVCR 2015
  • EFSC 1999
  • Fundamental
  • Price
  • NVCR $17.49
  • EFSC $54.02
  • Analyst Decision
  • NVCR Buy
  • EFSC Strong Buy
  • Analyst Count
  • NVCR 5
  • EFSC 4
  • Target Price
  • NVCR $26.60
  • EFSC $51.75
  • AVG Volume (30 Days)
  • NVCR 1.3M
  • EFSC 128.3K
  • Earning Date
  • NVCR 10-30-2024
  • EFSC 10-21-2024
  • Dividend Yield
  • NVCR N/A
  • EFSC 2.11%
  • EPS Growth
  • NVCR N/A
  • EFSC N/A
  • EPS
  • NVCR N/A
  • EFSC 4.72
  • Revenue
  • NVCR $549,964,000.00
  • EFSC $591,631,000.00
  • Revenue This Year
  • NVCR $16.23
  • EFSC N/A
  • Revenue Next Year
  • NVCR $6.09
  • EFSC $1.49
  • P/E Ratio
  • NVCR N/A
  • EFSC $11.27
  • Revenue Growth
  • NVCR 8.33
  • EFSC N/A
  • 52 Week Low
  • NVCR $10.87
  • EFSC $34.26
  • 52 Week High
  • NVCR $24.74
  • EFSC $54.88
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 43.24
  • EFSC 61.25
  • Support Level
  • NVCR $15.61
  • EFSC $51.31
  • Resistance Level
  • NVCR $17.31
  • EFSC $53.55
  • Average True Range (ATR)
  • NVCR 1.29
  • EFSC 1.33
  • MACD
  • NVCR 0.05
  • EFSC 0.18
  • Stochastic Oscillator
  • NVCR 11.59
  • EFSC 100.00

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About EFSC Enterprise Financial Services Corporation

Enterprise Financial Services Corporation is a financial holding company. It offers banking and wealth management services to individuals and business customers located in Arizona, California, Florida, Kansas, Missouri, Nevada, and New Mexico, in addition to loan and deposit production offices throughout the United States. The company offers a broad range of business and personal banking services including wealth management services. Lending services include commercial and industrial, commercial real estate, real estate construction and development, residential real estate, and consumer loans.

Share on Social Networks: